Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 33,858 shares at $3.54 ($120K) on 2023-08-10, disclosed to the SEC on 2023-08-10.
Scheduled sale ($120k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.54 | 16,929 | $60K | 50.0% |
| 2 | $3.54 | 16,929 | $60K | 50.0% |
| Total | $3.54 avg | 33,858 | $120K | 100% |
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |